Search clinical trials for: Candida infections in intertriginous areas

Total 460765 results

University of Oxford

Active, not recruiting

Safety and Immunogenicity of the Candidate Rabies Vaccine ChAdOx2 RabG

Rabies

United Kingdom
Fundación FLS de Lucha Contra el Sida, las Enfermedades...
Aelix Therapeutics

Completed

Study to Assess the Safety and Durability of Viral Control Beyond 24 Weeks of Analytical Treatment Interruption After the Administration of Candidate HIV-1 Vaccines DNA.HTI, MVA.HTI and ChAdOx1.HTI or Placebo in Early Treated HIV-1 Positive Individuals (ATI Extension of AELIX-002 Study)

HIV-1 Infection

Spain
Sanofi Pasteur, a Sanofi Company

Completed

Dose-ranging Study of an Investigational Yellow Fever Candidate Vaccine in Adults (VYF01)

Yellow Fever (Healthy Volunteers)

United States
Valneva Austria GmbH
National Institute for Health Research, United Kingdom

Completed

Dose Finding Study to Evaluate The Safety, Tolerability and Immunogenicity of an Inactiviated, Adjuvanted SARS-CoV-2 Virus Vaccine Candidate Against Covid-19 in Healthy Subjects

SARS-CoV-2 Virus Infection

United Kingdom
Jena University Hospital
Charite University, Berlin, Germany; Technical University of Munich; University...

Terminated

Seropositivity and Adverse Birth Events in Migrants From Bilharzia-endemic Areas (Bilharzia)

Schistosomiasis

Germany
Sanofi Pasteur, a Sanofi Company

Terminated

Study of a Candidate Clostridium Difficile Toxoid Vaccine in Subjects at Risk for C. Difficile Infection

Clostridium Difficile Infection

Sweden, United States, Mexico, Philippines, Singapore, Germany, France, Canada, Australia, Peru, Colombia, Brazil, Costa Rica, Denmark, Dominican Republic, Finland, Guatemala, Japan, Korea, Republic of, Panama, Poland, Puerto Rico, ... and more
Molecular Partners AG

Terminated

Safety, Tolerability and PK of Ensovibep (MP0420 - a New Candidate With Potential for Treatment of COVID-19)

COVID-19

United Kingdom
Zhejiang Clover Biopharmaceuticals, Inc.

Active, not recruiting

Immunogenicity and Safety Study of Adjuvanted SARS-CoV-2 (SCB-2019) Vaccine in Adultsin China

COVID-19

China
Virometix
Center of Vaccinology, Ghent, Belgium (CEVAC); Expert Clinical Services Organization...

Completed

Phase 1 Study to Evaluate the Safety and Immunogenicity of a Candidate Vaccine Against Respiratory Syncytial Virus

Acute Bronchiolitis Due to Respiratory Syncytial Virus

Belgium
Duke University
Children's Hospital of Philadelphia

Completed

BIOPIC: Fungal Biomarkers for Diagnosis and Response to Therapy for Pediatric Candidemia (BIOPIC)

Invasive Candidiasis

United States, Saudi Arabia, Greece, Spain
GlaxoSmithKline

Completed

A Study to Test GlaxoSmithKline's (GSK) Respiratory Syncytial Virus RSV Candidate Vaccine's Safety and Immune Response in Japanese Older Adults

Respiratory Syncytial Virus Infections

Japan
Zagazig University

Completed

Triple Antigen vs Monoantigen Immunotherapy for Warts

Triple Intralesional Immunotherapy Combination in Multiple Recalcitrant Warts

Egypt
University of Oxford

Completed

A Challenge Study to Assess the Safety, Immunogenicity and Efficacy of a Malaria Vaccine Candidate

Malaria

United Kingdom
Institut Pasteur
Coalition for Epidemic Preparedness Innovations; Themis Bioscience GmbH

Completed

Clinical Trial to Evaluate the Safety and Immunogenicity of the COVID-19 Vaccine (COVID-19-101)

COVID-19

Belgium, France
Duke University
National Institute of Allergy and Infectious Diseases (NIAID); Children's Hospital...

Completed

PEACE: Pediatric Antifungal Comparative Effectiveness (PEACE)

Pediatric Invasive Candidiasis

United States, Colombia, Canada, India, Saudi Arabia, Greece, Italy, Spain
CureVac

Completed

A Study to Assess the Safety, Reactogenicity and Immune Response of CureVac's Candidate Rabies mRNA Vaccine in Healthy Adults

Rabies

Belgium, Germany
National Institute of Allergy and Infectious Diseases...

Completed

Evaluating the Safety of Immediate Versus Deferred Isoniazid Preventive Therapy Among HIV-Infected Pregnant Women

HIV Infections | Tuberculosis

Haiti, South Africa, Thailand, Tanzania, Botswana, Zimbabwe, India, Uganda
Universitätsklinikum Hamburg-Eppendorf
Ludwig-Maximilians - University of Munich; Philipps University Marburg Medical... and other collaborators

Completed

Safety and Immunogenicity of the Candidate Vaccine MVA-SARS-2-S and a Booster Vaccination With a Licensed Vaccine Against COVID-19

Covid19

Germany
Ina-Respond
National Institute of Health Research and Development, Ministry of Health... and other collaborators

Completed

Validation of POC-CCA Rapid Urine Test for Qualitative Detection of Schistosoma Japonicum (SchisCCA)

Aged ≥2 Years in Schistosomiasis Affected Areas

Indonesia
National Institute of Allergy and Infectious Diseases...

Completed

Safety of the Candidate Vaccine C4-V3 Alone or With Interleukin-12 (IL-12) in HIV-Infected Patients Receiving Effective Anti-HIV Drug Therapy

HIV Infections

United States
University of Oxford

Terminated

Safety and Immunogenicity of a Candidate MERS-CoV Vaccine (MERS001)

MERS (Middle East Respiratory Syndrome)

United Kingdom
Pierre Van Damme
Bill and Melinda Gates Foundation; Centers for Disease Control and Prevention; PA... and other collaborators

Completed

A Phase 2 Study to Evaluate the Safety and Immunogenicity of Two Oral Poliovirus Vaccine Candidates

Poliomyelitis

Belgium
GlaxoSmithKline

Completed

Immunogenicity and Safety Study of GSK Biologicals' Candidate Malaria Vaccine Given at 6, 7.5 and 9 Months of Age in Co-administration With Measles, Rubella and Yellow Fever (YF) Vaccines Followed by a Booster of the Malaria Vaccine.

Malaria | Malaria Vaccines

Ghana
University of Sao Paulo
Fundação de Amparo à Pesquisa do Estado de São Paulo; Conselho Nacional de...

Active, not recruiting

CANnabiDiol for CoviD-19 pATiEnts With Mild to Moderate Symptoms (CANDIDATE)

SARS-CoV2

Brazil
Medical University of Graz
Medical University Innsbruck

Completed

NOBICS - NOvel BIomarker In Invasive CandidiasiS/Candida Sepsis (NOBICS)

Invasive Candidiasis

Austria
Direction Centrale du Service de Santé des Armées

Completed

Electrical Impedance Tomography: Collapse in Dependent Areas as a Predictor of Response to Prone Position Ventilation in COVID-19 Acute Respiratory Distress Syndrome (COVIDEIT)

Acute Respiratory Distress Syndrome | SARS-CoV Infection

France
Clover Biopharmaceuticals AUS Pty Ltd

Withdrawn

Immunogenicity and Safety of Adjuvanted SCB-2020S Vaccines in Adults

COVID-19
Scynexis, Inc.

Completed

Efficacy and Safety of Oral Ibrexafungerp (SCY-078) vs. Placebo in Subjects With Acute Vulvovaginal Candidiasis (Vanish 306)

Candida Vulvovaginitis

United States, Bulgaria
Scynexis, Inc.

Completed

Efficacy and Safety of Oral Ibrexafungerp (SCY-078) vs. Placebo in Subjects With Acute Vulvovaginal Candidiasis (VANISH 303)

Candida Vulvovaginitis

United States
Scynexis, Inc.

Completed

Dose-Finding Study of Oral Ibrexafungep (SCY-078) vs. Oral Fluconazole in Subjects With Acute Vulvovaginal Candidiasis (DOVE)

Candida Vulvovaginitis

United States
Yale University
National Institute of Mental Health (NIMH)

Completed

Adapting an Evidence-based Intervention for Stigma-related Stress, Mental Health, and HIV Risk for MSM of Color in Small Urban Areas (ESTEEM-conneCT)

HIV in MSM

United States
International Centre for Diarrhoeal Disease Research...
UNICEF; UBS Optimus Foundation

Unknown

Effectiveness Trial of Day-care vs. Usual Care of Severe Pneumonia & Malnutrition in Children (Day-care)

Pneumonia Childhood

Bangladesh
Vaccitech (UK) Limited
Clinical Network Services (CNS) Pty Ltd

Terminated

Efficacy of Candidate Influenza Vaccine MVA-NP+M1 in Adults

Influenza

Australia
King Saud University

Active, not recruiting

Curcumin; Rose Bengal; Denture Stomatitis

Cigarette Smoking | Candida Albicans Infection

Saudi Arabia
Islamia University of Bahawalpur

Completed

Social Acceptability of COVID-19 Vaccines in Pakistan

Social Acceptance, Social Anxiety

Pakistan
Aga Khan University
Bill and Melinda Gates Foundation; World Health Organization; UNICEF; Peshawar... and other collaborators

Unknown

To Develop, Implement and Evaluate the Polio Demonstration Project Comprising of a Community Based Intervention Package for Polio Eradication in Pakistan

Polio | Polio Sero Conversion | Polio Sero Prevalence | Immunization Coverage

Pakistan
U.S. Army Medical Research and Development Command
GlaxoSmithKline; United States Agency for International Development (USAID); Walter... and other collaborators

Completed

Double-blind, Randomized, Controlled Study of Safety, Immunogenicity and Efficacy of a Candidate Malaria Vaccine

Malaria, Falciparum

Kenya
Janssen Vaccines & Prevention B.V.
Institut National de la Santé Et de la Recherche Médicale, France; University...

Completed

A Study to Assess Safety, Tolerability, and Immunogenicity of Three Heterologus 2-dose Regimens of the Candidate Prophylactic Vaccines for Ebola in Healthy Adults

Ebola Viral Disease

France, United Kingdom
Nielsen BioSciences, Inc.

Completed

Candin Safety & Efficacy Study for the Treatment of Warts

Warts | Human Papilloma Virus

United States
Pierre Van Damme
Bill and Melinda Gates Foundation; Centers for Disease Control and Prevention; PA... and other collaborators

Completed

Phase 1 Novel Live Attenuated Serotype 2 Oral Polio Vaccine Study in Inactivated Polio Vaccine (IPV) Primed Adults (nOPV2M4a)

Poliomyelitis

Belgium
Daren K. Heyland
Pfizer; Queen's University; The Physicians' Services Incorporated Foundation

Terminated

Candida in the Respiratory Tract Secretions of Critically Ill Patients and The Efficacy of Antifungal Treatment (CANTREAT)

Ventilator Associated Pneumonia | Respiratory Tract Infection

Canada
Assistance Publique - Hôpitaux de Paris

Unknown

Dosage of Plasma 1, 3-β-D-glucan for the Diagnosis of Candidemia. (BDG-REA)

Infection, Fungal

France
Taiwan Liposome Company

Completed

Ampholipad Real-World Data in Taiwan

Fungal Infection | Febrile Neutropenia | Candida Infection | Cryptococcal Infections | Aspergillus Infection

Taiwan
Centre Hospitalier Universitaire de Saint Etienne
Sanofi Pasteur, a Sanofi Company

Completed

Ex Vivo Evaluation of Immunity Activation Face to S. Aureus Antigens and Adjuvants of a Vaccine Candidate in Cells From Haemodialysis Patients (ANTISTAPH)

Staphylococcus Aureus

France
Tulane University Health Sciences Center
National Institute of Allergy and Infectious Diseases (NIAID)

Completed

Studies of AQ-13, a Candidate Aminoquinoline Antimalarial, in Comparison With Chloroquine

Malaria

United States
Tulane University Health Sciences Center
Centers for Disease Control and Prevention

Completed

Food-Effect Bioavailability Study of AQ-13, a Candidate Antimalarial

Malaria

United States
University of Pittsburgh
University of Zimbabwe

Completed

HIV-Target Cell Response in Women Initiating Various Contraceptive Methods in High HIV-Incidence Areas: Zim CHIC (Zim CHIC)

HIV | Contraception | Microbiota | Immune Cells (Mucosal and Systemic)

Zimbabwe
King Abdullah International Medical Research Center
University of Oxford

Completed

A Clinical Trial to Determine the Safety and Immunogenicity of Healthy Candidate MERS-CoV Vaccine (MERS002)

Middle East Respiratory Syndrome Coronavirus

Saudi Arabia
University of Oxford

Unknown

A Study of a Candidate COVID-19 Vaccine (COV003)

Coronavirus

Brazil
National Institute of Allergy and Infectious Diseases...

Completed

Retrospective Chart Review of Candida Fungemia

Candida Fungemia

United States

Search clinical trials for: Candida infections in intertriginous areas

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Chile

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations